Celltech approval 'a year earlier'

ipsita's picture
Submitted by ipsita on Fri, 1997-12-05 10:30

Celltech, the biotechnology company, said that its antibody treatment for Crohn's disease-a serious bowel condition-could reach the US market up to a year earlier than expected after the regulator

thesaurus: 
Health
Main Topic: 
Health
Name of the Newspaper: 
Financial Times (London)
Mark Content Private(Internal): 
Clipping Type: 
DNB
External URL: 
Main Type: 
dte-DNB
Publication Date: 
05/12/1997